Issues / Issue · Aug 31 – Nov 20, 2026

Prescription Drug Pricing

39Members · 25 D · 14 R
51Actions · 34 D · 17 R
27States & territories · NH · WA · IA · PA lead
6Bills named

How the conversation moved

Democrat Republican · one dot = one action
Action typeWk ofAug 23Wk ofAug 309Wk ofSep 61Wk ofSep 135Wk ofSep 204Wk ofSep 277Wk ofOct 44Wk ofOct 112Wk ofOct 183Wk ofOct 252Wk ofNov 11Wk ofNov 82Wk ofNov 1511Total
Sent lettersTo agencies, companies, officials 6
HearingsHeld, testified or questioned 6
StatementsResponses to news 3
CriticizedA policy, decision or person 2
PraisedCredit for a decision or person 5
Visits and eventsTours, town halls, site visits 2
Filed or pushed billsNew, reintroduced or passed 24
Other 3

Emerging events

1 thread · 6 of 51 actions

INSULIN Act

2 members

  1. Oct 2Shaheen highlighted editorial support for INSULIN Act capping monthly insulin costs at $35.
  2. Oct 8Shaheen released video highlighting INSULIN Act and state gaps in insulin cost caps.
  3. Oct 21Schrier joined healthcare leaders to discuss her bill capping insulin costs at $35 monthly for all Americans.
  4. Nov 17Shaheen highlighted health advocacy support for bipartisan INSULIN Act to cap insulin costs at $35 monthly.
  5. Nov 17Shaheen pushed for bipartisan INSULIN Act passage to cap monthly insulin costs at $35.

6 actions →

What each party did · Democrats 34 · Republicans 17

  • 4Sent letters2
  • 3Hearings3
  • 3Statements0
  • 2Criticized0
  • 3Praised2
  • 1Visits and events1
  • 16Filed or pushed bills8
  • 2Other1

By state

Actions by members from each state, split by party. A joint release counts once for each member on it.

  • NH9
  • WA5
  • IA4
  • PA4
  • IL3
  • MI3
  • CO2
  • AL2

+19 more with fewer actions

Recognitions and tributes not counted.

Every action

51 actions · 53 releases
  1. Nov 20, 2026
    • Bill

      DBennet CO

      Introduced bill to lower prescription drug costs by expanding access to biosimilars.

      Release ↗

  2. Nov 19, 2026
    • Letter

      DShaheen NH $200M

      Led 243 lawmakers urging reauthorization of Special Diabetes Program before December 31 expiration.

      Release ↗

  3. Nov 17, 2026
    • Statement

      DShaheen NH

      Pushed for bipartisan INSULIN Act passage to cap monthly insulin costs at $35.

      ↳ INSULIN Act · Release ↗

    • Statement

      DShaheen NH

      Highlighted health advocacy support for bipartisan INSULIN Act to cap insulin costs at $35 monthly.

      ↳ INSULIN Act · Release ↗

    • Bill

      DWelch VT

      Pushed bipartisan bill to lower prescription drug costs by streamlining patent litigation for generic drugs.

      Release ↗

    • Criticism

      DMurray WA

      Opposed FDA nominee Heidi Overton's confirmation, citing anti-abortion extremism and medication abortion stance.

      Release ↗

    • Hearing

      RGrassley IA

      Held hearing examining competition and transparency to lower prescription drug costs.

      Release ↗

    • Hearing

      DDurbin IL

      Called for passage of bipartisan Drug-price Transparency for Consumers Act during Senate Judiciary Committee hearing.

      Release ↗

    • Hearing

      DDurbin IL

      Questioned witnesses about Medicare's authority to negotiate prescription drug costs during Senate Judiciary Committee hearing.

      Release ↗

    • Hearing

      RGrassley IA

      Chaired hearing on prescription drug costs and bipartisan bills to lower prices.

      Release ↗

    • Hearing

      RBritt AL

      Questioned witnesses at Senate Judiciary Committee hearing on lowering prescription drug costs.

      Release ↗

  4. Nov 11, 2026
    • Letter

      DAlsobrooks MD

      Warned against prediction markets allowing betting on clinical trials and drug approvals.

      Release ↗

    • Bill

      RBergman MI

      Introduced bipartisan bill to preserve prescription drug discounts for safety-net providers.

      Release ↗

  5. Nov 3, 2026
  6. Oct 29, 2026
    • Bill

      DMatsui CA

      Introduced bipartisan bill to protect patient access to affordable medications through 340B program.

      Release ↗

  7. Oct 27, 2026
  8. Oct 22, 2026
    • Letter

      RGrassley IA

      Urged FTC to complete pharmacy benefit manager investigation and release final recommendations.

      Release ↗

  9. Oct 21, 2026
  10. Oct 20, 2026
    • Statement

      DLarsen WA

      Praised Trump administration's delay of CBP rule that would restrict affordable prescription medication access.

      Release ↗

  11. Oct 16, 2026
    • Praise

      DShaheen NH

      Highlighted bipartisan support for INSULIN Act to cap monthly insulin costs at $35.

      Release ↗

  12. Oct 14, 2026
  13. Oct 9, 2026
    • Bill

      RBresnahan PA

      Introduced bipartisan bill to delay 340B drug rebate model implementation to protect patient access.

      Release ↗

    • Statement

      DCourtney CT

      Wrote op-ed calling for Congress to address rising health care premiums driven by drug costs.

      Release ↗

  14. Oct 8, 2026
  15. Oct 5, 2026
    • Criticism

      DDoggett TX

      Criticized insurers' preferential treatment of their own pharmacies in drug pricing.

      Release ↗

  16. Oct 2, 2026
  17. Oct 1, 2026
    • Letter

      DPocan WI

      Led letter to HHS and DHS urging continued allowance of prescription drug imports from Canada.

      Release ↗

    • Bill

      DBonamici OR

      Introduced bipartisan bill to establish 10,000 secure opioid disposal receptacles nationwide.

      Release ↗

  18. Sep 29, 2026
    • Bill

      DWarner VA

      Introduced bipartisan bill to improve pharmacy reimbursement data and reduce patient out-of-pocket costs.

      Release ↗

  19. Sep 28, 2026
  20. Sep 24, 2026
  21. Sep 23, 2026
    • Statement

      RCollins ME

      Discussed affordability, energy costs, and INSULIN Act on podcast.

      Release ↗

    • Bill

      RMarshall KS

      Sought unanimous consent for bill requiring upfront healthcare price transparency for patients.

      Release ↗

  22. Sep 18, 2026
    • Praise

      RMeuser PA

      Commended Trump administration for extending Most Favored Nation drug pricing to all state Medicaid programs.

      Release ↗

  23. Sep 17, 2026
  24. Sep 16, 2026
  25. Sep 15, 2026
    • Bill

      DMcBath GA

      Introduced bipartisan bill to increase transparency in prescription drug pricing.

      Release ↗

  26. Sep 14, 2026
    • Bill

      DSewell AL

      Introduced bill to extend Medicare Part D premium stabilization through 2029.

      Release ↗

  27. Sep 11, 2026
    • Letter

      RTenney NY

      Sent letter to HHS and CMS recommending Medicare incentives for American-made essential medicines.

      Release ↗

  28. Sep 3, 2026
  29. Sep 2, 2026
    • Bill

      DScholten MI

      Introduced two bills to lower prescription drug prices and protect hospital drug discounts.

      Release ↗

    • Bill

      DShaheen NH

      Highlighted bipartisan bill capping monthly insulin costs at $35 for insured and uninsured Americans.

      Release ↗

  30. Sep 1, 2026
    • Visit

      RHyde-Smith MS

      Met with pharmacists to discuss pharmacy benefit manager reform and prescription drug costs.

      Release ↗

  31. Aug 31, 2026
    • Bill

      RBilirakis FL

      Introduced bill to redirect Medicare Part D premium relief to seniors instead of insurance companies.

      Release ↗

Summaries, action types, amounts and positions are read from each press release by AI and can be wrong. Joint releases (same day, same action, matching title or amount) count once. How it works